Trial Profile
Study assessing safety and efficacy of dual antiplatelet therapy (DAPT) following implantation of Biolimus-A9 drug eluting coronary stents
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 13 Dec 2015
Price :
$35
*
At a glance
- Drugs Umirolimus (Primary) ; Antiplatelets
- Indications Acute coronary syndromes
- Focus Adverse reactions; Therapeutic Use
- 13 Dec 2015 New trial record